Publicaciones en colaboración con investigadores/as de University of Szeged (11)

2022

  1. Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

    European Urology Open Science, Vol. 40, pp. 38-45

  2. Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity

    Pharmaceutics, Vol. 14, Núm. 2

2021

  1. Author Correction: A community-based transcriptomics classification and nomenclature of neocortical cell types (Nature Neuroscience, (2020), 23, 12, (1456-1468), 10.1038/s41593-020-0685-8)

    Nature Neuroscience

  2. Publisher Correction: A community-based transcriptomics classification and nomenclature of neocortical cell types (Nature Neuroscience, (2020), 23, 12, (1456-1468), 10.1038/s41593-020-0685-8)

    Nature Neuroscience

2020

  1. A community-based transcriptomics classification and nomenclature of neocortical cell types

    Nature Neuroscience

2019

  1. Antiviral, antimicrobial and antibiofilm activity of selenoesters and selenoanhydrides

    Molecules, Vol. 24, Núm. 23

  2. Organoselenium compounds as novel adjuvants of chemotherapy drugs—a promising approach to fight cancer drug resistance

    Molecules, Vol. 24, Núm. 2

  3. Selenocompounds as novel antibacterial agents and bacterial efflux pump inhibitors

    Molecules, Vol. 24, Núm. 8

  4. Selenoesters and selenoanhydrides as novel agents against resistant breast cancer

    Anticancer Research, Vol. 39, Núm. 7, pp. 3777-3783

2017

  1. Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line

    Bioorganic and Medicinal Chemistry Letters, Vol. 27, Núm. 4, pp. 797-802

2016

  1. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance

    Bioorganic and Medicinal Chemistry Letters, Vol. 26, Núm. 12, pp. 2821-2824